Watermark
  Back to Search Results

BGB-A317-307

Completed

A Study of Tislelizumab in Combination With Chemotherapy Versus Chemotherapy in Advanced Lung Cancer

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-307

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT03594747

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20180292

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / 75 Years

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / 75 Years

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan